Compare
5 stocks, side by sideRelative performance · rebased to 100
IMVTPTGXPCVXSYREIBRX
| IMVTImmunovant, Inc. | PTGXProtagonist Therapeutics, Inc. | PCVXVaxcyte, Inc. | SYRESpyre Therapeutics, Inc. | IBRXImmunityBio, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 5/10 | 9/10 | 3/10 | 6/10 | 10/10 |
| Price | $39.52 | $145.88 | $60.36 | $90.61 | $8.30 |
| 1 month | -0.64% | -0.30% | +2.4% | -12% | +14% |
| 1 year | +159% | +160% | +88% | +435% | +242% |
| 5 year | +387% | +204% | +137% | -44% | -26% |
| P/E (TTM) | -14.3 | -80.6 | -8.8 | -1.5 | -9.8 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $7.9B | $7.9B | $7.8B | $7.7B | $8.2B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.